SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1360Thnx, To get excited about anti-DLL4 I would prefer first to see some animal daMiljenko Zuanic-12/3/2007
1359what's behind DLL4 in the Sanofi deal ? healthvalue.netbiotechmoney-12/3/2007
1358Yes, with this deal REGN did secure continuation of the R&D (cash burn rate)Miljenko Zuanic-11/29/2007
1357I think the market was clueless about the value of the regn antibody platform. Arkrw-11/29/2007
1356One way to think about this deal is that the stock purchase is partially based oBiomaven-11/29/2007
1355Well, no worries about hitting low single digits, repaying the $200M debt or no rkrw-11/29/2007
1354Regeneron Initiates Major Global Collaboration with Sanofi-aventis to Develop annigel bates-11/29/2007
1353Suckers and parasites, … of REGN board continue to enjoy free meal. In the past,Miljenko Zuanic-11/7/2007
1352PS: As always, information was leaked out!Miljenko Zuanic-11/1/2007
1351Message 23746543 It was too late! PDUFA Date for Rilonacept (IL-1 Trap) ExtendMiljenko Zuanic-11/1/2007
1350The letter is available at gene.com Genentech limits Avastin distribution Efferkrw-10/12/2007
1349DNA takes preemptive action against Avastin use for AMD: siliconinvestor.comDewDiligence_on_SI-10/11/2007
1348Press Release Source: Regeneron Pharmaceuticals, Inc. Regeneron Announces Positkenhott-10/1/2007
1347OPK UBS webcast (no endorsement implied re phase-3 AMD program): events.streamxDewDiligence_on_SI-9/26/2007
1346Lucentis data from NVS’ ex-US trials: siliconinvestor.comDewDiligence_on_SI-9/19/2007
1345Sanofi Trap development plan is mediocre. They have no clue how to differentiateMiljenko Zuanic-9/18/2007
1344Did anyone listen webcast? Presentation is available, but record is still offlMiljenko Zuanic-9/17/2007
1343Sanofi R&D Update: Oncology: Very ambitious program of studies to accelerarkrw-9/17/2007
1342From 10Q: <<During the second quarter of 2007, we exercised a purchase optMiljenko Zuanic-8/16/2007
1341From WSJ article on Icahn's investment company: The company also sharply intom pope-8/15/2007
1340Point well taken Miljenko about Enbrel/Humira success..I've been in upstate zeta1961-8/12/2007
1339This thread is peopled by admirable people. Since I had the effrontery to thank tom pope-8/12/2007
1338<i>Seems to me the conceptually right way to do this would be to simply coDewDiligence_on_SI-8/8/2007
1337<i>I really can't see the FDA even agreeing to non-inferiority of imprDewDiligence_on_SI-8/8/2007
1336Here's my 2c on this issue: I really can't see the FDA even agreeing toBiomaven-8/8/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News